Company / EPS (Diluted)
Yubo International Biotech Ltd EPS (Diluted) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.02
FY2025
5-year range
-$0.13 / -$0.02
FY2021-FY2025
Trend
+80.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 8 years, ranging from $-0.19 in FY2018 to $-0.02 in FY2025.
Based on SEC 10-K filings.
-0.02 in FY2025.
Improved from $-0.13 to $-0.02 over the past 5 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 80.0% year-over-year.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.02 | +80.0% |
| FY2024 | -$0.10 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2020 | -$0.13 | -8.3% |
| FY2019 | -$0.12 | +36.8% |
| FY2018 | -$0.19 | -72.7% |
| FY2017 | -$0.11 | -10.0% |
| FY2016 | -$0.10 | -11.1% |
| FY2015 | -$0.09 | +0.0% |